Gem
Device, Vascular, For Promoting Embolization. 510(k) K213385, from Obsidio, Inc. (Columbia, SC). Product code KRD, class 2.
As of Nov 19, 2026, K213385 is an FDA 510(k) held by Obsidio, Inc., substantially equivalent on Jul 1, 2022 after 261 days, with 1 recall tied to it in FDA's recall database.
- Review time: 261 days
- Recalls: 1
- Cited as a predicate by: 1 device
Obsidio GEM TM is indicated for use in the embolization of: • Hypervascular tumors, - Blood vessels to occlude blood flow for controlling bleeding/hemorrhaging in the peripheral vasculature.
- EmboCube Embolization GelatinK183120 · Biosphere Medical, S.A. · Aug 6, 2019
- OBSIDIO™ Conformable EmbolicK242507 · Boston Scientific · Oct 3, 2024
| Started | Recall | Status |
|---|---|---|
| Feb 20, 2024 | Z-1374-2024An investigation determined that delivery of the Obsidio embolic using the aliquot technique for lower gastrointestinal bleeding embolization poses a high risk of bowel ischemia. The most serious and the most common… | Open |
- LOBO Vascular Occlusion SystemK262798 · Okami Medical, Inc. · Oct 6, 2026
- UniPearls® Embolic MicrospheresK252812 · Suzhou Haowei Medical Technology Co., Ltd. · Jul 31, 2026
- OBSIDIO Conformable EmbolicK261488 · Boston Scientific Corporation · Jul 24, 2026
- Concerto Versa™ Detachable CoilK261866 · Medtronic, Inc. · Jun 24, 2026
- HARBOR Occlusion DeviceK260635 · Nuvascular, Inc. · Jun 12, 2026
- LOBO Vascular Occlusion SystemK260508 · Okami Medical, Inc. · Apr 10, 2026
- Concerto Versa™ Detachable CoilK253511 · Medtronic, Inc. · Jan 14, 2026
- Tembo Embolic SystemK253677 · Instylla, Inc. · Dec 15, 2025
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Oct 13, 2021
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.3300
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files